A team of international researchers led by Prof Martin Hegner, Investigator in CRANN and Trinity’s School of Physics developed an automated diagnostic platform that indicates bleeding – and thrombotic risks in one drop of blood within seconds (Nanoscale, “Towards personalised rapid label free miRNA detection for cancer and liver injury diagnostics in cell lysates and blood based samples”).
They exploit micro-resonators for real-time measurements of the evolving blood plasma clot strength. Along with the clinically measured clotting time, other parameters, from specific factor deficiency to global coagulation parameters to assess fibrinolysis, can be extracted.
These technical developments now open up the possibility to introduce a miniaturized global haemostasis assay with capability to fine-tune anti-coagulation therapies.
In collaboration with the multinational Hoffman-la-Roche they report a novel strategy for quick, reliable and quantitative diagnostics of expression patterns of non-coding short RNA in blood plasma or cell cultures. They directly detect label-free specific miRNA biomarkers relevant to cancer and adverse drug effects in blood-based samples (right image).
Image Credit: CRANN
News This Week
Frank Boehm contributes to ‘Immune Aspects of Biopharmaceuticals and Nanomedicines’ – CRC Press
Immune Aspects of Biopharmaceuticals and Nanomedicines 1st Edition Raj Bawa, Janos Szebeni, Thomas J Webster, Gerald F. Audette The enormous advances in the immunology of biotherapeutics and nanomedicines in the past two decades have [...]
Safety Panel Fears Soyuz Failure Could Exacerbate Commercial Crew Safety Concerns
LAS CRUCES, N.M. — Members of an independent NASA safety panel said they were worried that the Oct. 11 Soyuz launch failure could make safety concerns with the agency's commercial crew program even worse. [...]
Canadian astronaut says human space travel will advance ‘sooner than you think’
Canadian astronaut Col. Chris Hadfield (Ret.) on Friday said that human travel to space will happen sooner than we think, adding that the first destination will likely be a return trip to the moon. [...]
Ultrasmall targeted nanoparticles with engineered antibody fragments as an anti-cancer weapon
Antibody-based imaging of a particularly aggressive form of breast cancer is undergoing clinical trials worldwide, but the path from trial to application is being hampered by a major obstacle: safety. Concerns stem from inefficient [...]
New Method Allows Harvesting of 2D Materials in Minutes
Following the discovery of graphene in 2003, there has been considerable interest in other types of 2D materials. However, splitting a bulk crystal material into 2D flakes for use in electronics has proven hard [...]
Cybersecurity isn’t being taken seriously enough: MIT professor
The digital economy is set to unlock tremendous economic value for countries over time. But a common setback for the use of various new technologies is their vulnerability to hackers. That's because companies and [...]
Other published works by Frank Boehm
Frank Boehm (NanoApps Medical CEO) and Angelika Domschke contributed the chapter : “Application of a Conceptual Nanomedical Platform to Facilitate the Mapping of the Human Brain: Survey of Cognitive Functions and Implications”. The book [...]
Nanomedical Device and Systems Design: Challenges, Possibilities, Visions now available to rent on Kindle
To accommodate students who wish to read the book at an affordable cost, Nanomedical Device and Systems Design: Challenges, Possibilities, Visions by Frank Boehm (CEO NanoApps Medical Inc.) is available to rent on Kindle. This book benefits [...]
Leave A Comment